Christina Harbison, PharmD

Clinical Pharmacist
Prism Health North Texas
Dallas, Texas, United States

Disclosure information not submitted.

Presentation(s):

• 575 - PREFER-LA: Improved Adherence and Viral Control in Real-World Study of People with HIV (PWH) in the United States with Adherence Challenges on Oral Antiretroviral Therapy (ART) Switching to Cabotegravir + Rilpivirine Long-Acting (CAB+RPV LA)

  Wednesday, October 22, 2025
  11:06 AM - 11:18 AM US ET